NEW YORK (GenomeWeb News) – BG Medicine said late on Friday it has been notified by Nasdaq for the second time in less than six months that it does not fulfill a requirement for continued listing on the exchange.
Registering provides access to this and other free content.
Already have an account?Login Now.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.
This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.